HAE earnings date and last-quarter result: last quarter beat, P/E 38.25. Updated 2026-07-23.
Haemonetics (HAE) Research Hub
Haemonetics (HAE) trades on NYSE, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-10-26, shares last closed at 119.19 USD (+0.57%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 38.25, market cap 3.50B. This hub links to the full technical, earnings and options research available for HAE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NYSE, US |
| Last close | 119.19 USD (+0.57%) |
| 52-week range | 71.81 USD – 123.77 USD |
| Trend regime | Range |
| 14-day RSI | 73.1 (Overbought) |
| Trailing P/E | 38.25 |
| Market cap | 3.50B |
| Dividend yield | 0.00% |
Available research for HAE
Covered Call on HAE: how it works, illustrative setup around the real 119.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HAE: how it works, illustrative setup around the real 119.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HAE: how it works, illustrative setup around the real 119.19 USD price, max profit/loss, breakeven and when to use it. Educational.
HAE technical analysis: range, last 119.19 USD, RSI 73.1, 52w range 71.81 USD–123.77 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is HAE in?
Haemonetics (HAE) is classified under Healthcare (Medical - Instruments & Supplies), listed on NYSE, US.
Is HAE in an uptrend or downtrend?
As of 2026-10-26, HAE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HAE's trailing P/E ratio?
HAE's trailing P/E is 38.25, with a market cap of 3.50B. See the earnings research page for full valuation detail.